NCT06722963View on ClinicalTrials.gov

Comparison of the Efficacy of Intraperitoneal Instillation of Fentanyl Versus Nalbuphine As Adjuvants to Bupivacaine for Postoperative Pain Relief in Patients Undergoing Laparoscopic Cholecystectomy

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

January 1, 2026

Study Completion Date

February 1, 2026

Conditions
Laparoscopic Cholecystectomy
Interventions
DRUG

fentanyl

Fentanyl used as an adjuvant to bupivacaine for intraperitoneal instillation during laparoscopic cholecystectomy, a dose is 50 micrograms is commonly added to the local anesthetic solution.

DRUG

Nalbuphine

Nalbuphine in doses ranging from 10 mg have been studied as adjuvants to bupivacaine

All Listed Sponsors
lead

Assiut University

OTHER

NCT06722963 - Comparison of the Efficacy of Intraperitoneal Instillation of Fentanyl Versus Nalbuphine As Adjuvants to Bupivacaine for Postoperative Pain Relief in Patients Undergoing Laparoscopic Cholecystectomy | Biotech Hunter | Biotech Hunter